Bristol-Myers Squibb Company Ce PEG Ratio

Bristol-Myers Squibb Company Ce (CELG-RI) currently reports a PEG ratio of -1.18. That is below the sector sector average of 6.42. Use the charts on this page to explore Bristol-Myers Squibb Company Ce's PEG ratio history and peer comparisons.

Bristol-Myers Squibb Company Ce's PEG ratio of -1.18 is lower than the its sector sector average of 6.42. That is roughly 118.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Bristol-Myers Squibb Company Ce's market price to a fundamental measure such as earnings, sales, or book value. At -1.18, CELG-RI can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -1.18, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 6.42. From there, open related valuation or income-statement pages for Bristol-Myers Squibb Company Ce, and consider following CELG-RI for alerts when major investors trade the stock.